News

News

Claret Medical Sentinel Cerebral Protection System Celebral Protection

Claret Medical Inc. vascular and cardiac surgery procedures, announced that it has entered into an agreement for up to $18 million in a Series B financing.

Cook Medical Zilver PTX Drug Eluting Peripheral Stent Clinical Study China

Cook Medical has enrolled the first patient in the clinical study in China of its Zilver PTX Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal investigators,...

United States Medicaid Community Health Centers More Patients Fewer Uninsured

Community Health Centers (CHCs) across the country, which are the medical home for one in 15 people in the United States, are experiencing an overall increase in patients but fewer uninsured...

September 8, 2014 — Esaote North America announced its new MyLab Six ultrasound system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for sale...

September 8, 2014 — Eizo Inc. expanded its U.S. Food and Drug Administration (FDA) 510(k)-cleared large monitor system with the addition of the RadiForce LS580W monitor and LMM0802 large monitor...

Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy

Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien study published online in the ...

MicroVention LVIS Stent FDA Clearance July 2014

The U.S, Food and Drug Administration (FDA) has cleared MicroVention Inc.’s Low-Profile Visualized Intraluminal Support Device (LVIS and LVIS Jr.), which is a stent and delivery system...

September 5, 2014 — The number of uninsured is expected to decline by nearly half from 45 million in 2012 to 23 million by 2023 as a result of the coverage expansions associated with the...

September 5, 2014 — CardiacAssist announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Protek Duo veno‐venous cannula. The Protek Duo is...

A new analysis of clinical trial participation in the largest ongoing observational study of U.S. heart attack patients has found participants are not representative of the larger patient base,...

AirStrip $25 Million Mobile-enabled Healthcare AirStrip ONE

AirStrip, a provider of mobile healthcare applications, has raised $25 million in a strategic funding round led by the Gary & Mary West Health Investment Fund, Sequoia Capital and Wellcome...

September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-expanding valve and 14 French equivalent...

September 4, 2014 — St. Jude Medical announced a new multicenter clinical trial has found that using the company’s fractional flow reserve (FFR) technology changed the course of...

stem cells, cytori, stem cell therapy

The Cardiovascular Cell Therapy Research Network (CCTRN), has selected Cytori Therapeutics, Inc. to supply adipose-derived regenerative cells (ADRCs) for a clinical trial aimed at...

heart valve, heart surgery

For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one – and placed it just...

Allura Clarity

Angiographic imaging system vendors have developed several new technologies to address emerging cath lab trends, including the need to reduce radiation dose, improve image quality and enable...

bioresorbable stents, dissolving stents, Absorb stent, BVS

A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC) meetings is that bioresorbable stents...

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me of a race between vendors to build a better mouse trap. The main issue between cardiac echo,...

heart attack, JAMA, American Medical Association, acute coronary syndrome

In patients who experienced an acute coronary syndrome (ACS) event, use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 did not reduce the risk of recurrent...

CorMatrix, CanGaroo, ECM Envelope

CorMatrix Cardiovascular announced that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix CanGaroo ECM Envelope for use with...